Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model
Background: Anthracycline cardiotoxicity is a well-known complication of cancer treatment, and miRNAs have emerged as a key driver in the pathogenesis of cardiovascular diseases. This study aimed to investigate the expression of miRNAs in the myocardium in early and late stages of chronic anthracycl...
Saved in:
Main Authors: | Michaela Adamcova (Author), Helena Parova (Author), Olga Lencova-Popelova (Author), Petra Kollarova-Brazdova (Author), Ivana Baranova (Author), Marcela Slavickova (Author), Tereza Stverakova (Author), Petra Sauer Mikyskova (Author), Yvona Mazurova (Author), Martin Sterba (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
by: Makoto Kodama, et al.
Published: (2011) -
State of Vegetative Homeostasis in Children with Anthracycline-Induced Cardiomyopathy
by: T.V. Shatynska, et al.
Published: (2014) -
Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
by: Distefano Giuseppe
Published: (2009) -
The role of iron in anthracycline cardiotoxicity
by: Elena eGammella, et al.
Published: (2014) -
Updates in Anthracycline-Mediated Cardiotoxicity
by: Canan G. Nebigil, et al.
Published: (2018)